APA (7th ed.) Citation

Di Costanzo, F., Carlini, P., Doni, L., Massidda, B., Mattioli, R., Iop, A., . . . Gasperoni, S. (2005). Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: A randomised phase II trial of the Italian oncology group for clinical research (GOIRC). British Journal of Cancer, 93(2), 185. https://doi.org/10.1038/sj.bjc.6602640

Chicago Style (17th ed.) Citation

Di Costanzo, F., et al. "Gemcitabine with or Without Continuous Infusion 5-FU in Advanced Pancreatic Cancer: A Randomised Phase II Trial of the Italian Oncology Group for Clinical Research (GOIRC)." British Journal of Cancer 93, no. 2 (2005): 185. https://doi.org/10.1038/sj.bjc.6602640.

MLA (9th ed.) Citation

Di Costanzo, F., et al. "Gemcitabine with or Without Continuous Infusion 5-FU in Advanced Pancreatic Cancer: A Randomised Phase II Trial of the Italian Oncology Group for Clinical Research (GOIRC)." British Journal of Cancer, vol. 93, no. 2, 2005, p. 185, https://doi.org/10.1038/sj.bjc.6602640.